Evidence map›Paper›PMID 38397394›Full record

ArticleBiomolecules2024

Uptake of 18F-AV45 in the Putamen Provides Additional Insights into Alzheimer's Disease beyond the Cortex.

Zhengshi Yang, Jefferson W Kinney, Dietmar Cordes, The Alzheimer's Disease Neuroimaging Initiative

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. SequentialFrontiers in neurology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zhengshi YangCleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV 89106, USA.ORCID 0000-0002-9796-9680
Jefferson W KinneyDepartment of Brain Health, University of Nevada Las Vegas (UNLV), Las Vegas, NV 89154, USA.
Dietmar CordesCleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV 89106, USA.ORCID 0000-0001-6574-5546
The Alzheimer's Disease Neuroimaging Initiative
Cleveland Clinic · USUniversity of Nevada, Las Vegas · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - ResubmissionP20GM109025 · NIGMS · CLEVELAND CLINIC FOUNDATION · PI Robert J. Fox, Jefferson Kinney · 2015 to 2026
$22.8M
NVEDARC Clinical CoreP20AG068053 · NIA · CLEVELAND CLINIC FOUNDATION · PI WINT, DYLAN · 2020 to 2022
$3.3M
Machine and deep learning for finding multimodal imaging biomarkers in prodromal ADRF1AG071566 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI CORDES, DIETMAR, LOWE, MARK J · 2021 to 2021
$2.3M
Machine and deep learning for finding multimodal imaging biomarkers in prodromal ADR01AG071566 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI CORDES, DIETMAR, LOWE, MARK J · 2024 to 2025
$1.6M
NIA NIH HHS 1RF1AG071566NIA NIH HHS P20 AG068053NIA NIH HHS P20AG068053NIA NIH HHS R01 AG071566NIA NIH HHS RF1 AG071566NIA NIH HHS U01 AG024904NIGMS NIH HHS P20 GM109025NIGMS NIH HHS P20GM109025
6 · The paper itself

Abstract

Cortical uptake in brain amyloid positron emission tomography (PET) is increasingly used for the biological diagnosis of Alzheimer's disease (AD); however, the clinical and biological relevance of the striatum beyond the cortex in amyloid PET scans remains unclear. A total of 513 amyloid-positive participants having 18F-AV45 amyloid PET scans available were included in the analysis. The associations between cognitive scores and striatal uptake were analyzed. The participants were categorized into three groups based on the residual from the linear fitting between 18F-AV45 uptake in the putamen and the cortex in the order of HighP > MidP > LowP group. We then examined the differences between these three groups in terms of clinical diagnosis,

Indexed as

Alzheimer DiseaseCognitive DysfunctionAmyloidAmyloid beta-PeptidesHumansPositron-Emission TomographyPutamentau ProteinsAmyloidAmyloid beta-Peptidestau Proteins18F-AV45 PETAlzheimer’s diseaseamyloidputamenstriatum

Identifiers

PMID38397394
PMCPMC10886857
OpenAlexW4391316075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.